{"transactions":[{"id":3962553,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-17T20:16:03.000Z","date":"2018-04-13","kind":"exercise","acquired":false,"shares":8163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 11, 2014 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":3750,"derivative":{"exercise_price":14.07,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001209191-18-025170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025170/doc4.xml","form_type":"4"}},{"id":3962552,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-04-17T20:16:03.000Z","date":"2018-04-13","kind":"sale","acquired":false,"shares":8163,"price":20,"value":163260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001209191-18-025170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025170/doc4.xml","form_type":"4"}},{"id":3962551,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-04-17T20:16:03.000Z","date":"2018-04-13","kind":"exercise","acquired":true,"shares":8163,"price":14.07,"value":114853.41,"ownership":{"direct":true},"balance_after":22788,"source":{"system":"sec-edgar","filing":"0001209191-18-025170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118025170/doc4.xml","form_type":"4"}},{"id":3970581,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-04T20:09:33.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 26, 2017 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":53125,"derivative":{"exercise_price":3.5,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-18-023597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118023597/doc4.xml","form_type":"4"}},{"id":3970580,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-04T20:09:33.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":16605,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":715},"source":{"system":"sec-edgar","filing":"0001209191-18-023597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118023597/doc4.xml","form_type":"4"}},{"id":3970579,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-04-04T20:09:33.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":2278,"price":18.2984,"value":41683.7552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $18.069 to $18.80 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001209191-18-023597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118023597/doc4.xml","form_type":"4"}},{"id":3970578,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-04-04T20:09:33.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":1563,"price":3.5,"value":5470.5,"ownership":{"direct":true},"balance_after":16903,"source":{"system":"sec-edgar","filing":"0001209191-18-023597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118023597/doc4.xml","form_type":"4"}},{"id":3970577,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-04-04T20:09:33.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":715,"price":9.41,"value":6728.15,"ownership":{"direct":true},"balance_after":15340,"source":{"system":"sec-edgar","filing":"0001209191-18-023597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118023597/doc4.xml","form_type":"4"}},{"id":4017045,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested and became exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the January 26, 2017 grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter."}],"balance_after":54688,"derivative":{"exercise_price":3.5,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017044,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":1430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":17320,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":1430},"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017043,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":8087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 11, 2014 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":11913,"derivative":{"exercise_price":14.07,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":8087},"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017042,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":12.12,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":171},"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017041,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":15000,"price":23.0574,"value":345861.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $22.60 to $23.60 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017040,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":5312,"price":3.5,"value":18592.0,"ownership":{"direct":true},"balance_after":29625,"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017039,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":8087,"price":14.07,"value":113784.09,"ownership":{"direct":true},"balance_after":24313,"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017038,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":1430,"price":9.41,"value":13456.3,"ownership":{"direct":true},"balance_after":16226,"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4017037,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-05T23:39:40.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":171,"price":12.12,"value":2072.52,"ownership":{"direct":true},"balance_after":14796,"source":{"system":"sec-edgar","filing":"0001209191-18-016866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118016866/doc4.xml","form_type":"4"}},{"id":4077283,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-06T01:04:45.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the January 26, 2017 grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter."}],"balance_after":60000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-007710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118007710/doc4.xml","form_type":"4"}},{"id":4077282,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-02-06T01:04:45.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":15000,"price":20.5903,"value":308854.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  The shares were sold at prices ranging from $20.25 to $20.95 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001209191-18-007710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118007710/doc4.xml","form_type":"4"}},{"id":4077281,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-02-06T01:04:45.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":15000,"price":3.5,"value":52500.0,"ownership":{"direct":true},"balance_after":29625,"source":{"system":"sec-edgar","filing":"0001209191-18-007710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118007710/doc4.xml","form_type":"4"}},{"id":4083863,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-01T01:10:56.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":50250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the January 24, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":50250,"derivative":{"exercise_price":20.05,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":50250},"source":{"system":"sec-edgar","filing":"0001209191-18-006336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006336/doc4.xml","form_type":"4"}},{"id":4083862,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-02-01T01:10:56.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":8375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":14625,"source":{"system":"sec-edgar","filing":"0001209191-18-006336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118006336/doc4.xml","form_type":"4"}},{"id":4108601,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-03","kind":"exercise","acquired":false,"shares":8026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":171,"derivative":{"exercise_price":12.12,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":8026},"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108600,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":3959,"derivative":{"exercise_price":8.87,"expiration_date":"2025-07-26","underlying":"Common Stock","underlying_shares":209},"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108599,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":18750,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":782},"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108598,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-03","kind":"sale","acquired":false,"shares":8026,"price":18.05,"value":144869.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108597,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-03","kind":"exercise","acquired":true,"shares":8026,"price":12.12,"value":97275.12,"ownership":{"direct":true},"balance_after":14276,"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108596,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":6974,"price":16.35,"value":114024.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108595,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":209,"price":8.87,"value":1853.83,"ownership":{"direct":true},"balance_after":13224,"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4108594,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-01-05T00:34:49.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":782,"price":9.41,"value":7358.62,"ownership":{"direct":true},"balance_after":13015,"source":{"system":"sec-edgar","filing":"0001209191-18-002253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919118002253/doc4.xml","form_type":"4"}},{"id":4135332,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-12T23:08:49.000Z","date":"2017-12-11","kind":"tax_withholding","acquired":false,"shares":1252,"price":15.85,"value":19844.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of shares of common stock underlying RSUs."}],"balance_after":12233,"source":{"system":"sec-edgar","filing":"0001209191-17-065256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117065256/doc4.xml","form_type":"4"}},{"id":4135331,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-12T23:08:49.000Z","date":"2017-12-08","kind":"tax_withholding","acquired":false,"shares":2348,"price":16.9,"value":39681.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of shares of common stock underlying RSUs."}],"balance_after":13485,"source":{"system":"sec-edgar","filing":"0001209191-17-065256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117065256/doc4.xml","form_type":"4"}},{"id":4140789,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-07T00:17:38.000Z","date":"2017-12-04","kind":"exercise","acquired":false,"shares":11803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 12, 2013 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":8197,"derivative":{"exercise_price":12.12,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":11803},"source":{"system":"sec-edgar","filing":"0001209191-17-064261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064261/doc4.xml","form_type":"4"}},{"id":4140788,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-07T00:17:38.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":11803,"price":18,"value":212454.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-064261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064261/doc4.xml","form_type":"4"}},{"id":4140787,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-07T00:17:38.000Z","date":"2017-12-04","kind":"exercise","acquired":true,"shares":11803,"price":12.12,"value":143052.36,"ownership":{"direct":true},"balance_after":27636,"source":{"system":"sec-edgar","filing":"0001209191-17-064261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117064261/doc4.xml","form_type":"4"}},{"id":4144942,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T01:06:27.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":4168,"derivative":{"exercise_price":8.87,"expiration_date":"2025-07-26","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144941,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T01:06:27.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":19532,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":781},"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144940,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T01:06:27.000Z","date":"2017-11-30","kind":"exercise","acquired":false,"shares":13433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":20313,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":13433},"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144939,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T01:06:27.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":3197,"price":16.7,"value":53389.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold at prices ranging from $16.25 to $17.175 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144938,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T01:06:27.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":416,"price":8.87,"value":3689.92,"ownership":{"direct":true},"balance_after":19030,"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144937,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T01:06:27.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":781,"price":9.41,"value":7349.21,"ownership":{"direct":true},"balance_after":18614,"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144936,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T01:06:27.000Z","date":"2017-11-30","kind":"sale","acquired":false,"shares":13433,"price":16,"value":214928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":17833,"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144935,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T01:06:27.000Z","date":"2017-11-30","kind":"exercise","acquired":true,"shares":13433,"price":9.41,"value":126404.53,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,000 shares acquired by the Reporting Person on October 31, 2017 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":31266,"source":{"system":"sec-edgar","filing":"0001209191-17-063686","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063686/doc4a.xml","form_type":"4/A","original_submission_date":"2017-12-04"}},{"id":4144934,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T00:39:14.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":4168,"derivative":{"exercise_price":8.87,"expiration_date":"2025-07-26","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144933,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T00:39:14.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":19532,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":781},"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144932,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T00:39:14.000Z","date":"2017-11-30","kind":"exercise","acquired":false,"shares":13433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":20313,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":13433},"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144931,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T00:39:14.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":3197,"price":16.7,"value":53389.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold at prices ranging from $16.25 to $17.175 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144930,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T00:39:14.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":416,"price":8.87,"value":3689.92,"ownership":{"direct":true},"balance_after":19030,"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144929,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T00:39:14.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":781,"price":9.41,"value":7349.21,"ownership":{"direct":true},"balance_after":18614,"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144928,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T00:39:14.000Z","date":"2017-11-30","kind":"sale","acquired":false,"shares":13433,"price":16,"value":214928.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":17833,"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4144927,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-12-05T00:39:14.000Z","date":"2017-11-30","kind":"exercise","acquired":true,"shares":13433,"price":9.41,"value":126404.53,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,000 shares acquired by the Reporting Person on October 31, 2017 under the Issuer's Employee Stock Purchase Plan."}],"balance_after":31266,"source":{"system":"sec-edgar","filing":"0001209191-17-063672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117063672/doc4.xml","form_type":"4"}},{"id":4192629,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":3754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the option shares will vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":33746,"derivative":{"exercise_price":9.41,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":3754},"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192628,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":5416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":4584,"derivative":{"exercise_price":8.87,"expiration_date":"2025-07-26","underlying":"Common Stock","underlying_shares":5416},"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192627,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":5830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.41,"expiration_date":"2022-12-05","underlying":"Common Stock","underlying_shares":5830},"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192626,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":3754,"price":16,"value":60064.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192625,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":3754,"price":9.41,"value":35325.14,"ownership":{"direct":true},"balance_after":19587,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192624,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":5416,"price":15,"value":81240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192623,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":5416,"price":8.87,"value":48039.92,"ownership":{"direct":true},"balance_after":21249,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192622,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":5830,"price":15,"value":87450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4192621,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-10-04T20:22:26.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":5830,"price":5.41,"value":31540.3,"ownership":{"direct":true},"balance_after":21663,"source":{"system":"sec-edgar","filing":"0001209191-17-055830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117055830/doc4.xml","form_type":"4"}},{"id":4220011,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-01T22:19:23.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":10316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":5830,"derivative":{"exercise_price":5.41,"expiration_date":"2022-12-05","underlying":"Common Stock","underlying_shares":10316},"source":{"system":"sec-edgar","filing":"0001209191-17-051084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117051084/doc4.xml","form_type":"4"}},{"id":4220010,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-09-01T22:19:23.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":10316,"price":15,"value":154740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-051084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117051084/doc4.xml","form_type":"4"}},{"id":4220009,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-09-01T22:19:23.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":10316,"price":5.41,"value":55809.56,"ownership":{"direct":true},"balance_after":26149,"source":{"system":"sec-edgar","filing":"0001209191-17-051084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117051084/doc4.xml","form_type":"4"}},{"id":4220008,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-09-01T22:19:23.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":4684,"price":15,"value":70260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":15833,"source":{"system":"sec-edgar","filing":"0001209191-17-051084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117051084/doc4.xml","form_type":"4"}},{"id":4234357,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.12,"expiration_date":"2021-08-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234356,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-11","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.55,"expiration_date":"2021-12-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234355,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-11","kind":"exercise","acquired":false,"shares":3474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.99,"expiration_date":"2020-10-17","underlying":"Common Stock","underlying_shares":3474},"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234354,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-14","kind":"sale","acquired":false,"shares":5000,"price":11,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":20517,"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234353,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-14","kind":"exercise","acquired":true,"shares":5000,"price":5.12,"value":25600.0,"ownership":{"direct":true},"balance_after":25517,"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234352,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-11","kind":"sale","acquired":false,"shares":6474,"price":10,"value":64740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":20517,"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234351,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-11","kind":"exercise","acquired":true,"shares":3000,"price":2.55,"value":7650.0,"ownership":{"direct":true},"balance_after":26991,"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4234350,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-08-15T21:31:43.000Z","date":"2017-08-11","kind":"exercise","acquired":true,"shares":3474,"price":3.99,"value":13861.26,"ownership":{"direct":true},"balance_after":23991,"source":{"system":"sec-edgar","filing":"0001209191-17-049038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117049038/doc4.xml","form_type":"4"}},{"id":4257353,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-15T00:06:39.000Z","date":"2017-07-14","kind":"exercise","acquired":false,"shares":172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the stock option are fully vested and exercisable."}],"balance_after":3474,"derivative":{"exercise_price":3.99,"expiration_date":"2020-10-17","underlying":"Common Stock","underlying_shares":172},"source":{"system":"sec-edgar","filing":"0001209191-17-045272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117045272/doc4.xml","form_type":"4"}},{"id":4257352,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-07-15T00:06:39.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":14828,"price":10,"value":148280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":20517,"source":{"system":"sec-edgar","filing":"0001209191-17-045272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117045272/doc4.xml","form_type":"4"}},{"id":4257351,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-07-15T00:06:39.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":172,"price":10,"value":1720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."}],"balance_after":35345,"source":{"system":"sec-edgar","filing":"0001209191-17-045272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117045272/doc4.xml","form_type":"4"}},{"id":4257350,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-07-15T00:06:39.000Z","date":"2017-07-14","kind":"exercise","acquired":true,"shares":172,"price":3.99,"value":686.28,"ownership":{"direct":true},"balance_after":35517,"source":{"system":"sec-edgar","filing":"0001209191-17-045272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000120919117045272/doc4.xml","form_type":"4"}},{"id":4296649,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CBO"}}],"security":"Common Stock","published_at":"2017-06-03T00:26:49.000Z","date":"2017-06-01","kind":"sale","acquired":false,"shares":2000,"price":6.8,"value":13600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms."}],"balance_after":35345,"source":{"system":"sec-edgar","filing":"0001140361-17-023684","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117023684/doc1.xml","form_type":"4"}},{"id":4321520,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CBO"}}],"security":"Common Stock","published_at":"2017-05-15T23:42:46.000Z","date":"2017-05-12","kind":"sale","acquired":false,"shares":2000,"price":8.5,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired by the Reporting Person on April, 30, 2017 under the Issuer's Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms."}],"balance_after":37345,"source":{"system":"sec-edgar","filing":"0001140361-17-020870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117020870/doc1.xml","form_type":"4"}},{"id":4321519,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CBO"}}],"security":"Common Stock","published_at":"2017-05-15T23:42:46.000Z","date":"2017-05-11","kind":"sale","acquired":false,"shares":639,"price":6.5,"value":4153.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired by the Reporting Person on April, 30, 2017 under the Issuer's Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms."}],"balance_after":39345,"source":{"system":"sec-edgar","filing":"0001140361-17-020870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117020870/doc1.xml","form_type":"4"}},{"id":4477857,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CBO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-30T21:55:33.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter."}],"balance_after":75000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001140361-17-003488","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036117003488/doc1.xml","form_type":"4"}},{"id":4522582,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":126161,"kind":"person","name":"Herberts Curt A. III","position":1,"cik":"0001691262","reported_name":"Herberts Curt A. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP & CBO"}}],"security":"Common Stock","published_at":"2016-12-15T01:11:26.000Z","date":"2016-12-12","kind":"tax_withholding","acquired":false,"shares":4852,"price":3.05,"value":14798.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 3,333 and 12,500 shares subject to RSUs granted on December 11, 2014 and December 8, 2015 respectively, that will be issued as such units vest in accordance with their terms."}],"balance_after":33300,"source":{"system":"sec-edgar","filing":"0001140361-16-089716","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001233/000114036116089716/doc1.xml","form_type":"4"}}]}